Abstract
High-throughput screening in the 1536-well format has been largely restricted to solution-based and cell-based screens. In this article, we show the feasibility of a completely automated, robust scintillation proximity assay in the 1536-wen format that is suitable to identify inhibitors for a serine/threonine kinase from a compound library. The introduction of [33P]phosphate into a biotinylated peptide substrate mirrors the activity of the kinase. The peptide is immobilized on streptavidin-coated LEADseeker imaging beads and [33P]phosphate incorporation is detected with the LEADseeker imaging system of Amersham Pharmacia Biotech. To improve the liquid handling procedures for imaging bead suspensions in the low microliter range, we developed a novel trough with an integrated stirring function. A comparison of the 1536-well assay to a 384-well assay revealed a comparable assay quality with Z’ factors of about 0.7 for the 384-well format and 0.6 for the 1536-well format. In an automated screen of a random compound collection, 94.4% of the inhibitory compounds could be identified with both assay formats. Dose-response curves were performed for a selection of identified kinase inhibitors and revealed similar IC50values for both assay formats. © SAGE Social Science Collections.
Cite
CITATION STYLE
Sorg, G., Schubert, H. D., Buüttner, F. H., & Heilker, R. (2002). Automated high throughput screening for serine kinase inhibitors using a LEADSeekerTMscintillation proximity assay in the 1536-well format. Journal of Biomolecular Screening, 7(1), 11–19. https://doi.org/10.1177/108705710200700103
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.